New York, New York, United States Leeds Weld & Co. appeared to be the VC, which was created in 1920. The main department of described VC is located in the New York. The venture was found in North America in United States.
Among the most successful fund investment fields, there are B2B, Enterprise Software. Among the various public portfolio startups of the fund, we may underline Interwise Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Leeds Weld & Co., startups are often financed by UBS, Leeds Equity Partners, TPG. The meaningful sponsors for the fund in investment in the same round are Wall Street Technology Partners, STI Ventures, Lazard Technology Partners. In the next rounds fund is usually obtained by Wall Street Technology Partners, Lazard Technology Partners, UBS Capital Americas.
The top activity for fund was in 2002. The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2007.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Actemium | Sweden, Vastra Gotaland, Västra Götaland County |
| Aetius Capital | Central, Central Region, Singapore |
| Ahcof Holdings | Anhui, China, Hefei |
| AVLabs | Israel, Jerusalem, Jerusalem District |
| Burton Partnership | Florida, Tampa, United States |
| CNPq | Brasília, Brazil, Rio Grande do Norte |
| Coflex | Mexico, Nuevo León, Nuevo Leon |
| FIITJEE | Delhi, India, New Delhi |
| Finesco Capital | - |
| General Electric Pension Trust | Austin, Texas, United States |
| InNEVenture Fund | - |
| Minxiang Touzi | China, Shanghai |
| MSR Capital | Labuan, Labuan, Malaysia |
| MUUS | New York, New York, United States |
| Ningbo Hegu Touzi | China, Ningbo Shi, Zhejiang |
| RESOLUTE Partners | Connecticut, Southington, United States |
| Salix Pharmaceuticals | North Carolina, Raleigh, United States |
| Suanfarma Biotech | Alcobendas, Madrid, Spain |
| Synchrony Ventures | California, San Francisco, United States |
| Tongsheng Capital | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 